Back
Amylyx Pharmaceuticals Stock Predictions
Crowdfunding to IPO: Nasdaq's Next Breakout?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
30
AMLX
Amylyx Pharmaceuticals
Last Price:
$3.50
Seasonality Move:
-25.8%
7 Day Trial
ALL ACCESS PASS
$
7
The Tariff-Proof Asset in Your Pocket
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Amylyx Pharmaceuticals Stock Forecast
-
Is Amylyx Pharmaceuticals Stock Undervalued?The current Amylyx Pharmaceuticals [AMLX] share price is $3.78. The Score for AMLX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
-
AMLX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Amylyx Pharmaceuticals Stock Go Up Next Year?
Data Unavailable
Amylyx Pharmaceuticals Stock Rating
Data Unavailable
Amylyx Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
amylyx.com
52-Week Data
52-Week High:
7.27
52-Week Low:
1.58
Prediction Charts
Market Cap:
334.9M
Price in USD:
3.78
Volume:
772K
Beta:
-0.52
Technical Analysis
SMA50:
3.56
SMA100:
4.15
SMA200:
3.40
52-Wk Change:
44.27%
Stock Predictions
-
Is Amylyx Pharmaceuticals stock public?Yes, Amylyx Pharmaceuticals is a publicly traded company.
-
What is the Amylyx Pharmaceuticals stock quote today?The Amylyx Pharmaceuticals stock price is 3.78 USD today.
-
How to buy Amylyx Pharmaceuticals stock online?You can buy Amylyx Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Mar-14 | 3.73 | 3.63 | 3.83 | 3.54 |
| Mar-17 | 3.60 | 3.75 | 3.82 | 3.57 |
| Mar-18 | 3.76 | 3.64 | 3.77 | 3.60 |
| Mar-19 | 3.63 | 3.65 | 3.71 | 3.55 |
| Mar-20 | 3.65 | 3.73 | 3.84 | 3.64 |
| Mar-21 | 3.68 | 3.65 | 3.81 | 3.63 |
| Mar-24 | 3.72 | 3.78 | 3.79 | 3.61 |
| Mar-25 | 3.83 | 3.78 | 4.00 | 3.64 |
| Mar-26 | 3.74 | 3.81 | 3.87 | 3.59 |
| Mar-27 | 3.78 | 3.87 | 3.93 | 3.65 |
| Mar-28 | 3.80 | 3.66 | 3.85 | 3.55 |
| Mar-31 | 3.56 | 3.54 | 3.63 | 3.44 |
| Apr-1 | 3.51 | 3.34 | 3.54 | 3.30 |
| Apr-2 | 3.23 | 3.78 | 3.83 | 3.23 |
Amylyx Pharmaceuticals Earnings
Data Unavailable
Amylyx Pharmaceuticals Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings increase this quarter of $0.33 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.04 per share, and an increase next year of $0.10 per share.
* Amylyx Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.